AcquisitionsNov 2, 2026, 09:16 AM
Kimberly-Clark Completes Acquisition of Kenvue
AI Summary
Kimberly-Clark Corporation has successfully completed its acquisition of Kenvue Inc. on November 2, 2026. This strategic move unites leading portfolios, including 10 billion-dollar brands, to establish the company as the preeminent global consumer health and wellness leader. Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each Kenvue share. The company anticipates substantial run-rate synergies of approximately $2.1 billion, comprising cost and revenue synergies, and expects to leverage its proven growth engine to drive value creation.
Key Highlights
- Kimberly-Clark completed the acquisition of Kenvue Inc. on November 2, 2026.
- Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock per Kenvue share.
- The combined entity aims to be the preeminent global consumer health and wellness leader.
- The combined portfolio includes 10 billion-dollar brands such as Huggies, Listerine, Neutrogena, and Tylenol.
- Kimberly-Clark reaffirms anticipated run-rate synergies of approximately $2.1 billion.
- The acquisition is expected to create a differentiated financial framework with substantial synergies.
Price Impact
More from KMB